3 Black Friday Bargains: Barclays PLC, GlaxoSmithKline plc And Tesco PLC

Forget Black Friday, Barclays PLC (LON:BARC), GlaxoSmithKline plc (LON:GSK) and Tesco PLC (LON:TSCO) are the real bargains to buy this week

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s one of the biggest shopping weeks of the year, with Black Friday whipping consumers into a pre-Christmas frenzy by offering huge discounts in the shops.

The FTSE 100 is also throwing up some amazing discounts right now, and they will ultimately make you richer, rather than poorer. Here are my three favourite Black Friday bargains: Barclays (LSE: BARC) (NYSE: BCS.US), GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and Tesco (LSE: TSCO).

Barclays

At 237p, big bad bank Barclays is down 20% from its 52-week high of 297p… but it is showing signs of a recovery, following a solid 5% rise in Q3 profits to £4.94bn.

Barclays still faces a string of threats, including market rigging penalites, mis-selling scandals, challenger banks, crashing investment bank profits (down 38% in Q3) and an ongoing investigation into the current account market.

It has also shown signs of capital inadequacy, with a £12.8bn hole in its balance sheet. At Barclays, every day seems like Black Friday.

The outlook should slowly brighten as the billions keep rolling in, the dividend yield (now 2.73%) is repaired, and reputational damage finally patched up.

Barclays’ core businesses are delivering a return on equity of 10.5%, driven by personal and corporate banking, and the strength of its market-leading credit card Barclaycard.

These are solid operations, and you can buy them at a discount today.

GlaxoSmithKline

Trading at 1475p, GlaxoSmithKline is still 14% off its 52-week high, but the gap is starting to narrow. Its share price is up 7% in the last month, but it still offers one of the most enticing yields on the FTSE 100.

Glaxo currently yields 5.3%, more than 10 times base rate. Better still, today’s valuation of 13 times earnings (against 15 or 16 times) makes this a true Black Friday bargain.

Falling pharmaceuticals and vaccine sales in the US, disappointments in its consumer healthcare division, and the threat of further action over the Chinese bribery scandal have painted 2014 black for Glaxo. But unlike the bankers, I reckon it will learn its lessons quickly. And while you wait, keep re-investing those dividends.

Tesco

Britain’s biggest supermarket is so cheap it is almost impossible to resist, and even harder to trust. At 195p, its share price is 44% below its 52-week high. Customers hate it, investors hate it, regulators hate it: what’s to like?

Well, it’s under new management, and new boss Dave Lewis has a free hand to turn things round. Staff may go, stores may close, prices may fall and Tesco Bank may be sold off.

Almost anything could happen at Tesco right now. It is quite a gamble, even at 6.1 times earnings, but that’s how it’s is in the sales. You never really know if you’ve bagged a bargain, until you get it home.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. The Motley Fool UK owns shares of Tesco. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here are the 10 highest-FTSE growth stocks

The FTSE might not have a reputation for innovation and growth, but these top 10 stocks have produced incredible returns…

Read more »

Investing Articles

What on earth is going on with the S&P 500?

Our writer looks at why the S&P 500 has been volatile in December, as well as highlighting a FTSE 100…

Read more »

Stacks of coins
Investing Articles

1 penny stock mistake to avoid in 2025

Ben McPoland explores a rookie error common to penny stock investing, and also highlights a 19p small-cap that looks like…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

What can Warren Buffett teach an investor with £1,000?

Although Warren Buffett’s a billionaire, his investing lessons can be applied to far more modest portfolios. Our writer explains some…

Read more »

Light bulb with growing tree.
Investing Articles

Down 43%, could the ITM share price start rising again in 2025?

After news of the latest sales deal being inked, our writer revisits the ITM share price and considers if the…

Read more »

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

Is 2024’s biggest FTSE faller now the best share to buy for 2025?

Harvey Jones thought this FTSE 100 growth stock was the best share to buy for 2024, but was wrong. Yet…

Read more »

New year resolutions 2025 on desk. 2025 resolutions list with notebook, coffee cup on table.
Investing Articles

Legal & General has huge passive income potential with a forecast yield of almost 10% in 2025!

Harvey Jones got a fabulous rate of passive income from this top FTSE 100 dividend stock in 2024, and believes…

Read more »

Investing Articles

This stock market dip is my chance to buy cheap FTSE shares for 2025!

Harvey Jones was looking forward to a Santa Rally in December, but it looks like we're not going to get…

Read more »